News | November 02, 2012

Mevion Medical Systems Continues Manufacturing Ramp up for Mevion S250 Proton Therapy System

A fifth proton accelerator enters manufacturing line at Mevion headquarters

Mevion S250 Proton Therapy

November 2, 2012 —  Mevion Medical Systems announced the delivery of its fifth TriNiobium Core proton accelerator, the powerful proton source that is at the center of the revolutionary Mevion S250 Proton Therapy System. This accelerator will be delivered early next year to First Coast Oncology in Jacksonville, Fla. All 2013 and early 2014 Mevion S250 deliveries are already in the manufacturing stage.

“The Mevion S250 has redefined the economics, availability, and the future direction of proton therapy, by bringing the management and operation of proton therapy to the level of modern radiation therapy,” said Scot Ackerman, medical director for First Coast Oncology. “Our Mission has been to provide the most advanced radiation treatment for our cancer patients, and the Mevion S250 will allow us to offer to our patients the full benefits of proton therapy.”

The Mevion S250 proton therapy system represents the latest innovation in proton therapy, providing the same precise, non-invasive treatment advantages and capabilities of larger proton therapy systems but with a significantly reduced footprint, improved reliability, high patient throughput, more advanced clinical systems and lower implementation and operational costs. Powered by a patented gantry-mounted TriNiobium Core accelerator, the Mevion S250 has a footprint only slightly larger than a conventional linear accelerator.

In addition to the construction at First Coast Oncology, the Mevion S250 is installed at Washington University, St. Louis, Mo., and is under installation at Robert Wood Johnson University Hospital, New Brunswick, N.J. and Oklahoma University. An additional site in Florida, MD Anderson Cancer Center in Orlando just broke ground in September 2012.

More than a dozen Mevion S250 proton therapy systems are slated to be installed in the United States including five NCI Designated Comprehensive Cancer Center, and six international projects. “The simple and modular design of the Mevion S250 supports a lean and fast manufacturing process. This is a first in proton therapy which traditionally has been limited by the enormous size and complexity of the device”, says Joseph K. Jachinowski, chief executive officer of Mevion Medical Systems. The Mevion S250 is the only proton therapy system designed and manufactured in the United States, and has recently received United States Food and Drug Administration (FDA) 510(k) clearance and CE certification enabling Mevion customers to treat patients.

For more information: www.Mevion.com

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers. #ASTRO18 #ASTRO2018

A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.

Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American Societ...
Victoria Advisory Committee for Proton Therapy Launched at ASTRO 2018
News | Proton Therapy | October 29, 2018
At the 2018 American Society for Radiation Oncology (ASTRO) annual meeting, IBA announced the launch of the Victoria...
Beaumont Hospital Cancer Institute Performs First Irradiation of Spot Scanning Proton Arc Therapy Plan
News | Proton Therapy | October 25, 2018
IBA announced the first irradiation of a Spot Scanning Proton Arc (SPArc) plan at the Beaumont Health Proton Therapy...
Varian Introduces New ProBeam 360° Proton Therapy System
News | Proton Therapy | October 23, 2018
Varian announced its new single-room proton therapy system, ProBeam 360°, at the 2018 American Society of Radiation...
Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018

Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018.

Feature | Stereotactic Body Radiation Therapy (SBRT) | October 23, 2018 | By Greg Freiherr
With its shorter course of treatment,...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t
Feature | Proton Therapy | October 04, 2018 | By Adam Conner-Simons
Investigating inside the human body often requires cutting open a patient or swallowing long tubes with built-in...